Market Snapshot: Pancreatic Enzyme Products Get A Lift From FDA Rules
Executive Summary
Specialty pharma Eurand's official launch of its pancreatic enzyme product Zenpep at the end of November marks the entry of the second product to meet tighter FDA standards required by 2010
You may also be interested in...
After Setbacks, Eurand Has Zenpep In Its Step
A year after FDA approval, Eurand's Zenpep pancreatic enzyme therapy is rapidly gaining traction, and its manufacturer is looking for in-licensing opportunities in the U.S. in GI, cystic fibrosis, and orphan diseases.
After Setbacks, Eurand Has Zenpep In Its Step
A year after FDA approval, Eurand's Zenpep pancreatic enzyme therapy is rapidly gaining traction, and its manufacturer is looking for in-licensing opportunities in the U.S. in GI, cystic fibrosis, and orphan diseases.
This Little Pig-Free Product Goes To Market? Alnara's High Hopes For A PERT
Alnara claims its latest trial shows real-world effectiveness of liprotamase, formerly called Trizytek, and plans early 2010 NDA.